AxoGen(AXGN) - 2024 Q4 - Annual Results

Financial Performance - Axogen, Inc. announced preliminary, unaudited financial performance for Q4 and full year 2024 on January 10, 2025[5] - The company reported a revenue increase of 15% year-over-year for the full year 2024, reaching $100 million[5] - Axogen expects revenue growth of 10-15% for the full year 2025, projecting revenues between$ 110 million and $115 million[5] - The company reported a gross margin of 70% for the full year 2024, an increase from 68% in 2023[5] - Axogen's operating expenses increased by 12% year-over-year, totaling$ 40 million for 2024[5] User Growth - User data indicated a growth in the number of active accounts by 20% compared to 2023, totaling 5,000 active accounts[5] Product Development - The company is focusing on expanding its product line, with two new products expected to launch in Q2 2025[5] - Axogen is investing in R&D, allocating $5 million for new technology development in nerve repair solutions[5] Market Expansion - The company plans to enter two new international markets by the end of 2025, aiming to increase global market share[5] - Axogen is exploring potential acquisition opportunities to enhance its product offerings and market presence[5]